They follow completely different rules here's each one, side by side
Patients on metformin and another antihyperglycemic agent (N=229) and patients not on any antihyperglycemic agents (off therapy for at least 8 weeks, N=41) were randomized after a run-in period of approximately 10 weeks on metformin HCl (at a dose of at least 1500 mg per day) in monotherapy
Hours Monday & Wednesday 9am 4:30pm Tuesday & Thursday 9am 5:30pm Friday 9am 4pm Results vary
Your pharmacist may provide one if you do not have a sharps container
The 30-day trial window, explained plainly: Appetite management supplements don't produce results that can be measured on day three
In the study which was not peer reviewed the researchers examined a cohort of 413,557 patients who had been prescribed tirzepatide, liraglutide (Saxenda, Novo Nordisk), dulaglutide (Trulicity, Eli Lilly), injectable semaglutide (Wegovy, Novo Nordisk) or oral semaglutide (Rybelsus, Novo Nordisk) for a minimum of 180 days